Login
Evidence Feed
About
Conferences
New
Diagnostics
New
Top genes
New
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
Chr del(5q)
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Twitter
Trials
Reset Filters
VERI cancer hierarchy
x
x
x
x
Chr del(5q)
Myelodysplastic Syndrome
Chr del(5q)
Myelodysplastic Syndrome
lenalidomide
Sensitive: A1 - Approval
lenalidomide
Sensitive
:
A1
lenalidomide
Sensitive: A1 - Approval
lenalidomide
Sensitive
:
A1
Chr del(5q)
Acute Myelogenous Leukemia
Chr del(5q)
Acute Myelogenous Leukemia
venetoclax + ruxolitinib
Resistant: C3 – Early Trials
venetoclax + ruxolitinib
Resistant
:
C3
venetoclax + ruxolitinib
Resistant: C3 – Early Trials
venetoclax + ruxolitinib
Resistant
:
C3
Chr del(5q)
Acute Myelogenous Leukemia
Chr del(5q)
Acute Myelogenous Leukemia
cytarabine + decitabine + mitoxantrone
Sensitive: C3 – Early Trials
cytarabine + decitabine + mitoxantrone
Sensitive
:
C3
cytarabine + decitabine + mitoxantrone
Sensitive: C3 – Early Trials
cytarabine + decitabine + mitoxantrone
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login